Inovio Pharmaceuticals INO
NASDAQ INO
$1.18 -0.03 (-2.26%)
As of: Oct 2, 2026 · 11:02 AM EDT

Inovio Pharmaceuticals (INO) Debt Ratio (2023)

Updated

Inovio Pharmaceuticals' (INO) Debt Ratio came in at 0.10 for Q4 2023, up 14.9% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Debt Ratio (2023) Analysis & Trends

Since Q1 2023, Inovio Pharmaceuticals has reported Debt Ratio for 4 quarters.

  • According to Business Quant data, Debt Ratio for the three prior quarters was 0.09 (Q3 2023), 0.07 (Q2 2023) and 0.06 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inovio Pharmaceuticals 99.58 Mn 99.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.10
Sep 30, 2023 0.09
Jun 30, 2023 0.07
Mar 31, 2023 0.06
API Access

Inovio Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=INO&period=max&api_key=YOUR_API_KEY